Sağlıklı ve Diabet oluşturulmuş farelerin böbrek dokusunda katalaz enziminin RT-PCR ile gen ve immunohistokimyasal olarak protein ekspresyonu

Bu çalışma; deneysel Diabetes Mellitus (DM) oluşturulan farelerin böbrek dokusundaki katalaz enzimi (CAT) gen ekspresyonu düzeyinin, bu enzimin dokudaki lokalizasyonunun ve diabetli hayvanların böbrek dokusunda oluşan histolojik değişikliklerin belirlenmesi amacıyla yapıldı. Çalışmada kullanılan 36 adet Swiss albino fare, deneme (n=15), sham (n=15) ve kontrol (n=6) gruplarına ayrıldı. Deneme grubuna, 100 mg/kg dozda Streptozotosin (STZ) intraperitoneal (İP) yolla uygulandı. Deneme grubunda kan glikoz düzeyi 200 mg/dl’nin üzerinde olan fareler diabetik kabul edilerek çalışmaya alındı. CAT mRNA ekspresyon düzeyi Reverse Transkripsiyon-Polimeraz Zincir Reaksiyonuyla (RT-PCR), bu enzimin böbrek dokusundaki lokalizasyonu ise immunohistokimyasal yöntemle belirlendi. CAT gen ekpresyonu ve enzimatik aktivitesinin deneme grubunda sham ve kontrol gruplarına göre daha düşük olduğu tespit edildi (P

The gene expression profile by RT-PCR and immunohistochemical expression pattern of Catalase in the kidney tissue of both healthy and diabetic Mice

The aim of this study was to determine the gene expression pattern of catalase by RT-PCR technique, its tissue localization by immunohistochemistry method and the histological changes of DM kidney by routine histological techniques. In this study, 36 swiss albino mice were used and the animals were allocated into 3 groups as experimental (n=15), sham (n=15) and control (n=6) were used. STZ (100 mg/kg) was applied intraperitoneally (IP) to experimental group. Mice in which blood glucose level were above 200 mg/dl were included into DM group and considered as experimental group for the present study. Catalase gene expression level was determined by means of RT-PCR. Tissue localization of catalase enzyme was analysed by immunohistochemical method. Gene expression and enzyme activity of catalase from experimental group were found to be lower than those of the sham and control groups (P<0.05). Catalase staining was mainly observed in the renal cortex of all groups, whereas its reaction was relatively weaker in DM group than that of the other groups. Glycogen level was decreased in the proximal tubuls and hydropic degeneration was found especially in distal tubuls of the diabetic kidney. Result of the present study might make a contribution to future studies in the field of DM aiming to establish a better understanding of the relationship between antioxidants and DM.

___

  • 1.Handa H, Sakurama S, Nakagawa S, Yasukouchi T, Sakamotu W, Izumi H: Glandular kallikrein, renin and angiotensin converting enzyme of diabetic and hypertensive rats. Advan Exp Med Biol, 247, 443-448, 1989.
  • 2.McLennan S, Yue DK, Fisher E, Capogreco C, Heffernan S, Ross GR, Turtle JR: Deficiency of ascorbic acid in experimental diabetes. Relationships with collagen and polyol pathway abnormalities. Diabetes, 37 (3): 359-361, 1988.
  • 3.Pilkis SJ, El-Maghrabi MR, Clauss TH: Hormonal regulation of hepatic gluconeogenesis and glycolysis. Annu Rev Biochem, 57, 755-783, 1988.
  • 4.Sochor M, Kunjara S, Baquer NZ, Mclean P: Regulation of glucose metabolism in livers and kidneys of nod mice. Diabetes, 40 (11): 1467-1471, 1991.
  • 5.Herr RR, Jahnke HK, Argoudelis AD: The structure of streptozotocin. J Am Chem Soc, 89 (18): 4808-4809, 1967.
  • 6.Imaeda A, Kaneko T, Aoki T, Kondo Y, Nagase H: DNA damage and the effect of antioxidants in streptozotocin-treated mice. Food Chem Toxicol, 40, 979-987, 2002.
  • 7.Szkudelski T: The mecahnism of alloxan and streptozotosin action in β-cells of the rat pankreas. Physiol Res, 50, 536-546, 2001.
  • 8. Kondrad RJ, Mikolaenko I, Tolar JF, Liu K, Kudlow JE: The potential mechanism of the diabetogenic action of streptozotosin: Inhibition of pancreatic beta cell O-GlcNAcselective N-acetyl-beta-D-glucosaminidase. Biochem J, 356, 31-41, 2001.
  • 9. Corbett JA, Wang JL, Sweetland MA, Lancaster JR, McDaniel ML: Interleukin-1β induces the formation of nitric oxide by β-cells purified from rodent islets of Langerhans. Evidence for the β-cell as a source and site of action of nitric oxide. J Clin Invest, 90, 2384-2391, 1992.
  • 10. Grankvist K, Marklund S, Sehlin J, Taljedal IB: Superoxide dismutase, catalase and scavengers of hydroxyl radical protect against the toxic action of alloxan on pancreatic islet cells in vitro. Biochem J, 182, 17-25, 1979.
  • 11. Yazici C, Köse K: Melatonin: Karanlığın antioksidan gücü. Erciyes Univ Sağ Bil Derg, 13 (2): 56-65, 2004.
  • 12. Serafini M, Del RD: Understanding the association between dietary antioxidants, redox status and disease: Is the total antioxidant capacity the right tool? Redox Rep, 9 (3): 145-152, 2004.
  • 13. Cherubini A, Ruggiero C, Polidori MC, Mecocci P: Potential markers of oxidative stress in stroke. Free Radic Biol Med, 39, 841-852, 2005.
  • 14. Memisogullari R, Taysi S, Bakan E, Capoglu I: Antioxidant status and lipid peroxidation in type II diabetes mellitus. Cell Biochem Func, 21, 291-296, 2003.
  • 15. Sumner JB, Dounce AL: Crystalline catalase. J Biol Chem, 121, 417-424, 1937.
  • 16. Masters C, Holmes R: Peroxisome: New aspects of cell physiology and biochemistry. Physiol Rew, 57, 866-882, 1977.
  • 17. Klotz MG, Klassen GR, Loewen PC: Phylogenetic relationships among prokaryotic and eukaryotic catalases. Mol Biol Evol, 14 (9): 951-958, 1997.
  • 18. Karabulut AB, Özerol E, Temel İ, Gözükara EM, Akyol Ö: Yaş ve sigara içiminin eritrosit katalaz aktivitesi ve bazT hematolojik parametreler üzerine etkisi. İnönü Univ TTp Fak Derg, 9 (2): 85-88, 2002.
  • 19. Kanitkar M, Bhonde R: Existence of islet regenerating factors within the pancreas. Rev Diabet Stud, 1 (4): 185-192, 2004.
  • 20. Sechi LA, Ceriello A, Griffin CA, Catena C, Amstad P, Schambelan M, Bartoli E: Renal antioxidant enzyme mRNA levels are increased in rats with experimental diabetes mellitus. Diabetologia, 40, 23-29, 1997.
  • 21. Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal Biochem, 162, 156-159, 1987.
  • 22. Kocamis H: Functional profiles of growth related genes during embryogenesis and postnatal development of chicken and mouse skeletal muscle. Doktora Tezi, Morgantown, West Virginia, 2001.
  • 23. Yamamura M, Uyemura K, Deans RJ, Weinberg K, Rea TH, Bloom BR, Modlin RL: Defining protective responses to pathogens: Cytokine profiles in lepropsy lesions. Science, 254, 277-279, 1991.
  • 24. Ferret PJ, Soum E, Negre O, Fradelizi D: Auto-protective redox buffering systems in stimulated macrophages. BMC Immunol, 3, 1-13, 2002.
  • 25. Luna LG: Manual of Histologic Staining Methods of Armed Forces Institute of Pathology. 3th ed., pp. 222-226. Mc Graw-Hill Book Comp, New York, 1968.
  • 26. Hsu SM, Raine L, Fanger H: Use of Avidin-Biotin- Peroxidase Complex (ABC) in immunoperoxidase techniques: A comparison between ABC and unlabelled antibody (PAP) procedures. J Histochem Cytochem, 29, 577-580, 1981.
  • 27. Aebi H: Catalase in Vitro. Methods Enzymol, 105, 121126, 1984.
  • 28. SPSS 12.0: Windows and Smart Viewer, 2003.
  • 29. Göçmen C, Seçilmiş A, Kumcu EK, Ertuğ PU, Önder S, Dikmen A, Baysal F: Effects of vitamin E and sodium selenate on neurogenic and endothelial relaxion of corpus cavernosum in the diabetic mouse. Eur J Pharmacol, 398, 93-98, 2000.
  • 30. Wada J, Zhang H, Tsuchiyama Y, Hiragushi K, Hida K, Shikata K, Kanwar YS, Makino H: Gene expression profile in streptozotosin-induced diabetic mice kidneys undergoing glomerulosclerosis. Kidney Int, 59, 1363-1373, 2001.
  • 31. Hayashi K, Haneda H, Koya D, Maeda S, Isshiki K, Kikkawa R: Enhancement of glomerular heme oxygenase-1 expression in diabetic rats. Diabetes Res Clin Pract, 52, 85-96, 2001.
  • 32. Fujita A, Sasaki H, Ogawa K, Matsuno S, Matsumoto E, Furuta H, Nishi M, Nakao S, Tsuno T, Taniguchi H, Nanjo K: Increased gene expression of antioxidant enzymes in KKAy diabetic mice but not in STZ diabetic mice. Diabetes Res Clin Pract, 69, 113-119, 2005.
  • 33. Andallu B, Varadacharyulu NC: Antioxidant role of mulberry (Morus indica L. cv. Anantha) leaves in streptozotocindiabetic rats. Clin Chim Acta, 338, 3-10, 2003.
  • 34. Johkura K, Usuda N, Liang Y, Nakazawa A: Immunohistochemical localization of peroxisomal enzymes in developing rat kidney tissues. J Histochem Cytochem, 46 (10): 1161-1173, 1998.
  • 35. Morikawa S, Harada T: Immunohistochemical localization of catalase in mammalian tissues. J Histochem Cytochem, 17, 30-35, 1969.
  • 36. Aliciguzel Y, Ozen I, Aslan M, Karayalcin U: Activities of xanthine oxidoreductase and antioxidant enzymes in different tissues of diabetic rats. J Lab Clin Med, 142 (3): 172-177, 2003.
  • 37. Wu YG, Lin H, Qi XM, Wu GZ, Qian H, Zhao M, Shen JJ, Lin ST: Prevention of early renal injury by mycophenolate mofetil and its mechanism in experimental diabetes. Int Immunopharmacol, 6, 445-453, 2006.
  • 38. Reddi AS, Bollineni JS: Selenium-deficient diet induces renal oxidative stress and injury via TGF-β1 in normal and diabetic rats. Kidney Int, 59, 1342-1353, 2001.
  • 39. Limaye PV, Raghuram N, Sivakami S: Oxidative stres and gene expression of antioxidant enzymes in the renal cortex of streptozotocin-induced diabetic rats. Mol Cell Biochem, 243, 147-152, 2003.
  • 40. Haan JB, Stefanovic N, Nicolic-Paterson D, Scurr LL, Croft KD, Mori TA, Hertzog P, Kola I, Atkins RC, Tesch GH: Kidney expression of glutathione peroxidase-1 is not protective against streptozotosin-induced diabetic nephropathy. Am J Physiol Renal Physiol, 289, 544-551, 2005.
  • 41. Öztürk F, Iraz Mustafa, Eşrefoğlu M, Kuruş M, Gül M, Otlu A: Deneysel diyabetin sTçan böbreklerinde meydana getirdiği histolojik değişiklikler. İnönü Univ TTp Fak Derg, 12 (1): 1-4, 2005.
  • 42. Vardi N, Iraz M, Gül M, Öztürk F, Uçar M, Otlu A: Diyabetin böbreklerde neden olduğu histolojik değişiklikler üzerine aminoguanidinin iyileştirici etkileri. T Klin J Med Sci, 26, 599-606, 2006.
Kafkas Üniversitesi Veteriner Fakültesi Dergisi-Cover
  • ISSN: 1300-6045
  • Yayın Aralığı: Yılda 6 Sayı
  • Başlangıç: 1995
  • Yayıncı: Kafkas Üniv. Veteriner Fak.
Sayıdaki Diğer Makaleler

Developmental Orthopaedic Diseases in foals

ÖZLEM ŞENGÖZ ŞİRİN, Zeki ALKAN

Veteriner ilaçları satış yetkisinin veteriner hekimliği açısından değerlendirilmesi: III. ilaç satış yetkisi ile kalıntılar arasındaki ilişki

ABDULLAH ÖZEN, ERHAN YÜKSEL, Özlem DOĞAN

Sağlıklı ve Diabet oluşturulmuş farelerin böbrek dokusunda katalaz enziminin RT-PCR ile gen ve immunohistokimyasal olarak protein ekspresyonu

SEYİT ALİ BİNGÖL, Hakan KOCAMIŞ

Nahcivan Özerk Cumhuriyetinde bal Arısı (Apis mellifera L.) kolonilerinin gelişim süresinin hızlandırılması yollarının araştırılması

Ali TAHİROV, Habib HÜSEYNOV, Elsever ESEDOV

The effects of L-ergothioneine and L-ascorbic acid on the in vitro maturation (IVM) and embryonic development (IVC) of sheep oocytes

Yavuz ÖZTÜRKLER, SAVAŞ YILDIZ, ÖRSAN GÜNGÖR, ŞÜKRÜ METİN PANCARCI, Cihan KAÇAR, UMUT ÇAĞIN ARI

Nisin dirençlilik ve regülasyon genlerinin Laktisin 481 üreticisi L. lactis subsp. lactis MBLL9 suşunda anlatımı

Ercan KOCA, Nefise AKKOÇ, PINAR ŞANLIBABA, MUSTAFA AKÇELİK

Lucilia sericata (Diptera: calliphoridae) larvalarına bağlı kedide Ocular ve köpekte travmatik myiasis olguları

HASAN EREN, SÜLEYMAN AYPAK, KEREM URAL, Fırat SEVEN

Japon bıldırcınlarında (Coturnix coturnix japonica) canlı ağırlığa ait özelliklerin genetik parametrelerinin REML metodu ile hesaplanması

MEHMET SARI, MUSTAFA SAATCI, MUAMMER TİLKİ

Chewing lice (Phthiraptera) species found on Turkish shorebirds (Charadriiformes)

Bilal DİK, Çağan Hakkı ŞEKERCIOĞLU, MEHMET ALİ KIRPIK, Sedat İNAK, UĞUR USLU

The contribution of differentiated bone marrow stromal stem cell-loaded biomaterial to treatment in critical size defect model in rats

MEHMET İBRAHİM TUĞLU, Feyzan Özdal KURT, HÜSEYİN KOCA, Aydın SARAÇ, Turgay BARUT, Aycan KAZANÇ